Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2017 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 16 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome

  • Authors:
    • Yu Wang
    • Chunxia Zheng
    • Xia Wang
    • Ke Zuo
    • Zhihong Liu
  • View Affiliations / Copyright

    Affiliations: National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, P.R. China
  • Pages: 6276-6284
    |
    Published online on: August 22, 2017
       https://doi.org/10.3892/mmr.2017.7329
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Nephrotic syndrome is not a single disease; rather, it is a term for numerous diseases and pathological types. Renal biopsy is of use in determining the diagnosis and prognosis, and for guiding treatment; however, the use of this intervention is limited due to its invasive nature. Abnormal kidney‑derived proteins in the urine of patients provide useful information regarding numerous pathological processes that occur in the kidneys, and may be considered a potential non‑invasive biomarker for kidney disease. Proteomic analysis exhibits the advantage of being high‑throughput and has previously been used to identify biomarkers of disease. The present study aimed to identify abnormal kidney‑derived proteins in the urine of patients with nephrotic syndrome using a novel proteomic strategy. Urine samples from 5 patients with nephrotic syndrome were subjected to acetone precipitation and albumin/immunoglobulin G depletion prior to analysis by two‑dimensional liquid chromatography tandem mass spectrometry. The resulting data were compared to a publicly available proteomic database of normal human plasma/urine and normal human kidney in PeptideAtlas, and of normal human kidney in the Human Protein Atlas. Candidate biomarkers were validated using ELISA analysis in 60 patients with nephrotic syndrome: 30 with focal segmental glomerulosclerosis (FSGS) and 30 with minimal change disease (MCD), as well as in 30 healthy controls. The initial screening identified 809 proteins in the urine of patients with nephrotic syndrome. A total of 13/809 proteins were additionally present in the kidney proteome of PeptideAtlas and the Human Protein Atlas, although not in normal human urine and normal human plasma according to PeptideAtlas; these were referred to as ‘kidney‑derived disease‑associated proteins’. One of the kidney‑derived disease‑associated proteins, ubiquitin‑60S ribosomal protein L40 (UBA52) was observed to be increased in the urine of patients compared with normal controls [Creatinine, 637 ng/mg (216‑1,851) vs. 1.89 ng/mg (1.37‑3.33), P<0.001; and 18.58 ng/mg (11.11‑46.25) vs. 1.89 ng/mg (1.37‑3.33), P<0.001)], and the urinary UBA52 levels were significantly increased in patients with FSGS compared with in patients with MCD (P<0.001). In conclusion, the present study identified potential novel urinary protein biomarkers for nephrotic syndrome, in addition to an extensive urinary proteomic profile of patients with nephrotic syndrome.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Sancho-Martínez SM, Prieto-García L, Blanco-Gozalo V, Fontecha-Barriuso M, López-Novoa JM and López-Hernández FJ: Urinary proteomics in renal pathophysiology: Impact of proteinuria. Proteomics Clin Appl. 9:636–640. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Somparn P, Hirankarn N, Leelahavanichkul A, Khovidhunkit W, Thongboonkerd V and Avihingsanon Y: Urinary proteomics revealed prostaglandin H(2)D-isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritis. J Proteomics. 75:3240–3247. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Zhang X, Jin M, Wu H, Nadasdy T, Nadasdy G, Harris N, Green-Church K, Nagaraja H, Birmingham DJ, Yu CY, et al: Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int. 74:799–807. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Rossing K, Mischak H, Dakna M, Zürbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L and Rossing P: PREDICTIONS Network: Urinary proteomics in diabetes and CKD. J Am Soc Nephrol. 19:1283–1290. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P, Pavone B, Perfumo F, Urbani A, Scolari F and Ghiggeri GM: Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol. 17:3139–3148. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS and Arthur JM: Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 18:913–922. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Siwy J, Zoja C, Klein J, Benigni A, Mullen W, Mayer B, Mischak H, Jankowski J, Stevens R, Vlahou A, et al: Evaluation of the zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles. PLoS One. 7:e513342012. View Article : Google Scholar : PubMed/NCBI

8 

Pieper R, Su Q, Gatlin CL, Huang ST, Anderson NL and Steiner S: Multi-component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome. Proteomics. 3:422–432. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Pernemalm M, Lewensohn R and Lehtiö J: Affinity prefractionation for MS-based plasma proteomics. Proteomics. 9:1420–1427. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Björhall K, Miliotis T and Davidsson P: Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics. 5:307–317. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Desrosiers RR, Beaulieu E, Buchanan M and Béliveau R: Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins. Cell Biochem Biophys. 49:182–195. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Echan LA, Tang HY, Ali-Khan N, Lee K and Speicher DW: Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics. 5:3292–3303. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Roche S, Tiers L, Provansal M, Seveno M, Piva MT, Jouin P and Lehmann S: Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: The more the better? J Proteomics. 72:945–951. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Mebazaa A, Vanpoucke G, Thomas G, Verleysen K, Cohen-Solal A, Vanderheyden M, Bartunek J, Mueller C, Launay JM, Van Landuyt N, et al: Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: Identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure. Eur Heart J. 33:2317–2324. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Wang C, Wei LL, Shi LY, Pan ZF, Yu XM, Li TY, Liu CM, Ping ZP, Jiang TT, Chen ZL, et al: Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis. Sci Rep. 5:156152015. View Article : Google Scholar : PubMed/NCBI

16 

Kurono S, Kaneko Y, Matsuura N, Oishi H, Noguchi S, Kim SJ, Tamaki Y, Aikawa T, Kotsuma Y, Inaji H and Matsuura S: Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry. Proteomics Clin Appl. 10:605–613. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Cao TH, Quinn PA, Sandhu JK, Voors AA, Lang CC, Parry HM, Mohan M, Jones DJ and Ng LL: Identification of novel biomarkers in plasma for prediction of treatment response in patients with heart failure. Lancet. 385 Suppl 1:S262015. View Article : Google Scholar : PubMed/NCBI

18 

Jia L, Zhang L, Shao C, Song E, Sun W, Li M and Gao Y: An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes. PLoS One. 4:e51462009. View Article : Google Scholar : PubMed/NCBI

19 

Farrah T, Deutsch EW, Omenn GS, Sun Z, Watts JD, Yamamoto T, Shteynberg D, Harris MM and Moritz RL: State of the human proteome in 2013 as viewed through peptideatlas: Comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven human proteome project. J Proteome Res. 13:60–75. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al: Towards a knowledge-based human protein atlas. Nat Biotechnol. 28:1248–1250. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Zhang L, Wen Q, Mao HP, Luo N, Rong R, Fan JJ and Yu XQ: Developing a reproducible method for the high-resolution separation of peritoneal dialysate proteins on 2-D gels. Protein Expr Purif. 89:196–202. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Wiśniewski JR, Zougman A, Nagaraj N and Mann M: Universal sample preparation method for proteome analysis. Nat Methods. 6:359–362. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Thongboonkerd V, Chutipongtanate S and Kanlaya R: Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: Quantity, quality, and variability. J Proteome Res. 5:183–191. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Beeken M, Lindenmeyer MT, Blattner SM, Radón V, Oh J, Meyer TN, Hildebrand D, Schlüter H, Reinicke AT, Knop JH, et al: Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases. J Am Soc Nephrol. 25:2511–2525. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang Y, Zheng C, Wang X, Zuo K and Liu Z: Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome. Mol Med Rep 16: 6276-6284, 2017.
APA
Wang, Y., Zheng, C., Wang, X., Zuo, K., & Liu, Z. (2017). Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome. Molecular Medicine Reports, 16, 6276-6284. https://doi.org/10.3892/mmr.2017.7329
MLA
Wang, Y., Zheng, C., Wang, X., Zuo, K., Liu, Z."Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome". Molecular Medicine Reports 16.5 (2017): 6276-6284.
Chicago
Wang, Y., Zheng, C., Wang, X., Zuo, K., Liu, Z."Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome". Molecular Medicine Reports 16, no. 5 (2017): 6276-6284. https://doi.org/10.3892/mmr.2017.7329
Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y, Zheng C, Wang X, Zuo K and Liu Z: Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome. Mol Med Rep 16: 6276-6284, 2017.
APA
Wang, Y., Zheng, C., Wang, X., Zuo, K., & Liu, Z. (2017). Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome. Molecular Medicine Reports, 16, 6276-6284. https://doi.org/10.3892/mmr.2017.7329
MLA
Wang, Y., Zheng, C., Wang, X., Zuo, K., Liu, Z."Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome". Molecular Medicine Reports 16.5 (2017): 6276-6284.
Chicago
Wang, Y., Zheng, C., Wang, X., Zuo, K., Liu, Z."Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome". Molecular Medicine Reports 16, no. 5 (2017): 6276-6284. https://doi.org/10.3892/mmr.2017.7329
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team